Search results
Results From The WOW.Com Content Network
Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH).
The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying cancer-screening company Grail without regulators' approval, the latest setback for the deal.
The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in ...
(Reuters) -A U.S. appeals court on Friday struck down a Federal Trade Commission order against Illumina's purchase of cancer diagnostic test maker Grail, a former subsidiary, saying the agency had ...
Illumina claimed that Oxford Nanopore infringed its patents on the use of a biological nanopore, Mycobacterium smegmatis porinA (MspA), for sequencing systems. [64] [65] In August 2016 the parties settled their lawsuit. [66] In February 2020, Illumina filed a patent infringement suit against BGI relating to its "CoolMPS" sequencing products. [67]
Even still, Icahn is pressing on with a lawsuit he filed against the Illumina board of directors last year. In the suit, Icahn accused the board of breaching their fiduciary duty by completing the ...
Bank of America must be used to shelling out billions to settle class-action lawsuits by now. One settlement involving the company in 2012 stipulated it reimburse shareholders $2.43 billion for ...
Facebook recently paid 1.4 million Illinois residents $397 in 2022 as part of a class action lawsuit for facial recognition breaches through its “Tag Suggestions” feature, per CNBC.